Biohaven licenses IgG degrader portfolio to Ono for Asia

🌐 Investing.com (Cyprus) —
Biohaven licenses IgG degrader portfolio to Ono for Asia

AI Summary

Biohaven licensed its IgG degrader portfolio to Ono for markets in Asia. The headline does not disclose financial terms, specific countries, or further details about the licensing arrangement.

Deals Health Biohaven Ono licensing agreement IgG degrader Asia biopharmaceuticals

Read original source →